Zura Bio Ltd (ZURA)
4.29
-0.35
(-7.54%)
USD |
NASDAQ |
Apr 30, 16:00
4.29
0.00 (0.00%)
After-Hours: 20:00
Zura Bio Price to Book Value: 3.152 for April 30, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| April 29, 2024 | 3.409 |
| April 26, 2024 | 3.240 |
| April 25, 2024 | 2.660 |
| April 24, 2024 | 2.432 |
| April 23, 2024 | 2.557 |
| April 22, 2024 | 2.432 |
| April 19, 2024 | 2.432 |
| April 18, 2024 | 2.711 |
| April 17, 2024 | 2.300 |
| April 16, 2024 | 2.234 |
| April 15, 2024 | 2.307 |
| April 12, 2024 | 2.469 |
| April 11, 2024 | 2.109 |
| April 10, 2024 | 2.043 |
| April 09, 2024 | 2.035 |
| April 08, 2024 | 2.05 |
| April 05, 2024 | 2.006 |
| April 04, 2024 | 2.131 |
| April 03, 2024 | 2.153 |
| April 02, 2024 | 2.153 |
| April 01, 2024 | 2.094 |
| March 28, 2024 | 1.888 |
| March 27, 2024 | 1.705 |
| March 26, 2024 | 1.661 |
| March 25, 2024 | 1.763 |
| Date | Value |
|---|---|
| March 22, 2024 | 1.506 |
| March 21, 2024 | 2.124 |
| March 20, 2024 | 2.234 |
| March 19, 2024 | 2.263 |
| March 18, 2024 | 2.300 |
| March 15, 2024 | 2.344 |
| March 14, 2024 | 2.329 |
| March 13, 2024 | 2.447 |
| March 12, 2024 | 2.395 |
| March 11, 2024 | 2.373 |
| March 08, 2024 | 2.381 |
| March 07, 2024 | 2.366 |
| March 06, 2024 | 2.388 |
| March 05, 2024 | 2.564 |
| March 04, 2024 | 2.608 |
| March 01, 2024 | 2.697 |
| February 29, 2024 | 2.704 |
| February 28, 2024 | 2.763 |
| February 27, 2024 | 2.719 |
| February 26, 2024 | 2.689 |
| February 23, 2024 | 2.682 |
| February 22, 2024 | 2.689 |
| February 21, 2024 | 2.704 |
| February 20, 2024 | 2.777 |
| February 16, 2024 | 2.866 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.506
Minimum
Mar 22 2024
19.80
Maximum
Jun 20 2023
4.777
Average
3.807
Median
Price to Book Value Benchmarks
| GT Biopharma Inc | 0.5541 |
| Outlook Therapeutics Inc | -- |
| IMAC Holdings Inc | -- |
| Nkarta Inc | 1.721 |
| 180 Life Sciences Corp | -- |
Price to Book Value Related Metrics
| Price | 4.29 |
| Earnings Yield | -102.4% |
| Market Cap | 187.02M |